Below are five ways you can stay engaged, informed, and inspired this week.
For more, check The Michael J. Fox Foundation's COVID-19 resource hub for information to support the worldwide Parkinson's community through this challenging time, and our virtual public events hub for a complete list of upcoming community-hosted offerings.
As always, we're in this together. |
1. News in Context: LRRK2 Therapies Speeding toward Patients after $1B Biotech Deal
A drug that may slow or stop Parkinson’s disease is moving closer to patients’ hands after a $1 billion deal. This partnership speeding therapeutic testing is built on work from The Michael J. Fox Foundation to “de-risk” LRRK2 drug development and support measurement tools.
|
2. Tune in Live from Instagram: How to Boost Your Virtual Fundraising
Join MJFF’s Director of Community Events Stephanie Paddock on Wednesday, August 12 at 3 p.m. ET, for an Instagram Live discussion on virtual fundraising, ways that you can stay connected to our Tour de Fox community and doubling your impact with our 20-day $20K match.
|
3. My Research Journey: Chipping Away at A Cure
Kim Barnett, 50, of Lafayette, Colorado has completed 11 Fox Insight study visits and multiple research studies through MJFF’s Trial Finder . In this guest blog, she shares how knowledge became power after her father’s Parkinson’s diagnosis and helped steer many of her future life choices.
|
4. Watch On Demand: The Doctor Will See You Now…Virtually
Our expert panelists discuss telemedicine — which is on the rise during the COVID-19 pandemic — and how it can work for Parkinson’s. We talk with a patient and care partner about how to make the most of a virtual visit with a doctor, and we take questions from the audience.
|
5. #TogetherAtHome: Making the Most of your Telemedicine Visit
Many people are now seeing their doctor virtually, through the computer or smartphone. These virtual appointments — telemedicine — are a valuable tool for continuing care. Join us online as we discuss tips for making the most of these online visits.
|
|
|
No hay comentarios:
Publicar un comentario